Page last updated: 2024-08-21

isoxazoles and trametinib

isoxazoles has been researched along with trametinib in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kakefuda, R; Tajima, N; Tanimoto, A; Watanabe, Y; Yamaguchi, T1
Choi, J; Jin, HR; Kim, SW; Lee, DH; Lee, MH; Nam, KY; Oh, B; Park, KS; Yang, H1

Other Studies

2 other study(ies) available for isoxazoles and trametinib

ArticleYear
Suppressive effect of an orally active MEK1/2 inhibitor in two different animal models for rheumatoid arthritis: a comparison with leflunomide.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2012, Volume: 61, Issue:5

    Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Collagen Type II; Cytokines; Enzyme Inhibitors; Humans; Interleukin-6; Isoxazoles; Leflunomide; Lipopolysaccharides; Lymphocyte Activation; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Mice; Mice, Inbred ICR; Pyridones; Pyrimidinones; Rats; Rats, Sprague-Dawley

2012
The HSP90 inhibitor, NVP-AUY922, sensitizes KRAS-mutant non-small cell lung cancer with intrinsic resistance to MEK inhibitor, trametinib.
    Cancer letters, 2016, Mar-01, Volume: 372, Issue:1

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Female; HSP90 Heat-Shock Proteins; Humans; Isoxazoles; Lung Neoplasms; Mice, Inbred BALB C; Mice, Nude; Mitogen-Activated Protein Kinase Kinases; Mutation; Protein Kinase Inhibitors; Proto-Oncogene Proteins p21(ras); Pyridones; Pyrimidinones; Resorcinols; Signal Transduction; Time Factors; Tumor Burden; Xenograft Model Antitumor Assays

2016